Introduction: Taipu Bioscience Co., Ltd. was established in April 2004 with a registered capital of US$35.2 million. It is a company integrating the research and development, production, sales and medical testing services of medical diagnostic reagents and diagnostic instruments. BIOHITECH LIMITED. At present, it has passed the GMP and Class III in vitro diagnostic reagent quality system assessment and certification, and obtained the production license for medical device in vitro diagnostic reagents. The company currently has more than 400 employees, of whom 81% have a college degree or above, 32% have master's degrees and doctoral degrees, 22 have senior professional titles, 8 are doctoral supervisors, and 5 are entitled to special allowances from the State Council. The company has established a strong product research and development platform, with 1 Fujian Provincial Molecular Diagnostic Technology Engineering Laboratory, 1 Taipu-Canada Maimeihua Molecular Diagnostic Strategic Alliance, and 3 R&D centers (Fuzhou, Beijing, Xi'an). In addition, the company also We have established industry-university-research strategic cooperation alliances with scientific research institutes such as Peking University, Fourth Military Medical University, Beijing Tuberculosis Control Institute, Fuzhou University, Fujian Medical University, Yale University and Columbia University in the United States, and built a molecular diagnostic R&D platform that is in sync with the world. We have achieved major breakthroughs in many key technologies in the field of genetic diagnosis, and have developed more than 40 series of new products with internationally advanced levels and independent intellectual property rights. The Taipu Biotechnology Park, with a total investment of approximately 300 million yuan and an area of ??approximately 68,549 square meters, is located in Siming Industrial Park, Huandonghai District, Xiamen City. It is expected to be completed in 2011. By then, it will be the largest molecular diagnostic reagent and supporting facility in Fujian Province and even East China. Instrument R&D and production base. In the past three years, the company has obtained four national invention patents and more than 20 national, provincial, ministerial and municipal science and technology and industrialization funding. The company currently has seven series of products and more than 40 varieties. Including liquid-based cytology product series, nucleic acid hybridization product series, PCR product series, colloidal gold rapid diagnostic products, histopathology product series, vaginitis rapid detection quadruple card, etc. These products have independent intellectual property rights and have reached the international advanced level. . The company's products are sold to more than 30 provinces and cities across the country except Taiwan and Tibet, with more than 2,000 users. While Taipu produces and sells molecular diagnostic products, it has also established clinical testing centers in Beijing, Fujian and other places to provide advanced, fast and convenient medical testing and pathological diagnosis services to the whole society. Taipu's achievements in the field of genetic diagnosis have been highly recognized and valued by the Fujian Provincial Government and Fuzhou Municipal Government. In August 2006, the "First China-Fujian Genetic Engineering Technology and High-end Medical Device Industry Development Summit Forum" organized by Taipu Bioscience Co., Ltd. was held in Fuzhou. Vice Governor Li Chuan, Vice Mayor Zhu Hua and the provincial and municipal officials Leaders from all major departments attended the meeting and delivered speeches. Leaders of major provincial and municipal departments also visited Taipu Company for inspection and guidance many times, and made important instructions to “focus on supporting enterprises with independent property rights like Taipu.” In the "2006-2008 Fujian Province Pharmaceutical Industry Development Action Plan" formulated by the Fujian Provincial Government, Taipu Company's "Fluorescent PCR In Vitro Test Kit R&D and Industrialization" project was listed as the first batch of key implementation projects to be supported. The "2007-2009 Fujian Province Medical Device Industry Development Action Plan" formulated by the Fujian Provincial Economic and Trade Commission listed Fujian Taipu as one of 17 key supported medical device companies, and the company's two projects were included in 36 key implementation projects. .
Legal representative: Yao Mingfeng
Establishment date: 2006-05-15
Registered capital: 45 million yuan
Industrial and commercial registration number : 350100100176649
Enterprise type: Limited liability company (foreign-invested enterprise legal person sole proprietorship)
Company address: 4th Floor, Building 9, No. 9, Jintang Road, Jianxin Town, Cangshan District, Fuzhou City, Fujian Province< /p>